ON DEMAND WEBINAR
Duration: 1 hour​

Are you among the 43% of employers considering coverage of GLP-1s such as Wegovy for weight loss or Ozempic for diabetes medication for your workforce next year? If so, you need to ask yourself the following: Who should qualify for coverage? How do you monitor safe and effective use? Do you need to adjust your population health targets? 

These questions can help you gain perspective on the true cost of diabetes, obesity and other chronic conditions and increase your understanding of a primary care’s critical role in a holistic care approach and the safe prescription of medications. In this webinar discussion, Accolade physicians discuss:

• Clinical guidance on rolling out GLP-1s out to your company.
• Key considerations for primary care physicians when diagnosing and deciding if GLP-1s are the right medication.
• Setting goals and expectations when it comes to a patient-centered support model.

SPEAKERS

Connie Hwang, MD
Chief Medical Officer
Accolade

James Wantuck, MD
Associate Chief Medical Officer, Accolade
Co-founder, PlushCare

 

Katie Miller Blakemore
Senior Manager, Events
Accolade
Moderator